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Abstract 
Intravenous acetaminophen/paracetamol (IVA/P) within a multimodal analgesic approach 
has been examined in adult surgical populations, but we wanted to understand what was known 
about its use in children who have surgery. We examined the state of science on IVA/P in a 
multimodal analgesic approach in children who have surgery.  With the assistance of a health 
sciences research librarian, we searched across three major bibliographic databases (PubMed, 
Embase, and Cochrane Central Register of Controlled Trials) using the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses guidelines. Each report was evaluated 
according to our inclusion criteria: (1) research focused on IVA/P in a multimodal approach; (2) 
focused on pediatric population (<18); (3) full-text article in an English language peer-reviewed 
journal. Publications were independently analyzed by two reviewers to discern the quality, 
approach, findings, and limitations to be considered. A total of N = 3781 articles were first 
identified. After excluding: a) duplicates (n = 689); and b) not meeting inclusion criteria (n = 
3087), we included a total of N = 5 articles. A multimodal analgesic approach that uses IVA/P in 
pediatric surgical patients has the potential to produce opioid-sparring effects, decrease reported 
pain scores over time, and improves aspects of outcomes. Yet, because there are so few studies 
in children, more research with rigorous designs and comparable outcome measures is needed. 
We make a strong case for why IVA/P should be researched, especially in intellectually impaired 
children or children whose underlying health might warrant sparing use of opioids for analgesia. 
Keywords: Acetaminophen, Intravenous, Multimodal, Opioid-sparring, Pain Scores, 
Paracetamol, Pediatric 
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Analgesic use of Intravenous Acetaminophen/Paracetamol in the Pediatric Surgical Patient: 
A Systematic Review and Synthesis 
Pediatric inpatient surgery cases are abundant in the United States and pain is a 
complication of surgery. In 2009, there were 6,393,803 pediatric (<18 years of age) inpatient 
discharges for surgery (Tzong, et al., 2012). Pain is defined by the International Association for 
the Study of Pain (IASP) as, “An unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” (Merskey & Bogduk, 
1994). Damage to tissue from a surgical procedure can result in nociceptive stimuli interpreted as 
pain (Zeller, 2008). Pain management is complex and often relies on the use of multiple drugs 
and non-pharmacologic techniques to target the multiple and diverse mechanisms of nociceptive 
stimuli, increase the patient’s tolerance to the stimuli, and address the patient’s emotional 
response to nociception. Surgical pain is a type of nociceptive pain, and nociceptive pain is more 
common in pediatric patients. If unmanaged or under managed, nociceptive pain can lead to 
longitudinal undesired effects as a result of the plasticity of children’s afferent and efferent pain 
pathways (Lundeberg, 2015; Bhutta & Anand, 2002; Fitzgeral & Beggs, 2001).   
 Pain is typically treated through a multimodal approach to minimize side effects 
associated with the use of one drug or one therapy and to maximize analgesia by targeting the 
multiple sources of nociceptive stimuli (Verghese & Hannallah, 2010; Yaster, 2010). A 
multimodal approach to pain management is defined by the American Society of 
Anesthesiologists Task Force on Acute Pain Management (ASATFAPM) as, “the administration 
of two or more drugs that act by different mechanisms for providing analgesia” (2012). The 
ASATFAPM supports the use of multimodal pain management when possible. In children 
undergoing surgery the ASATFAPM states, “Analgesic therapy should. . . unless contraindicated 
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involve a multimodal approach” (2012). Evidence in adult populations suggests that IVA/P is an 
important component to multimodal analgesia and has opioid-sparring effects (Memis, 2010; 
Remy, Marret, & Bonnet, 2005).  
 Intravenous acetaminophen (Ofirmev [Brand Name] or Paracetamol) (IVA/P) is a 
relatively new administration route of a commonly used and relatively benign analgesic; the oral 
and rectal forms of acetaminophen have circulated since 1878 (Bertolini, 2006). Acetaminophen 
is a unique analgesic drug, compared to non-steroidal anti-inflammatory drugs (NSAIDs), in that 
it is not effective for inflammation. However, it does not produce gastrointestinal, cardiac, or 
renal effects that NSAIDs are known to produce. The mechanism of analgesic action for 
acetaminophen is still under question. There is insufficient evidence that acetaminophen works 
through inhibition of cyclooxygenase (COX) enzymes, specifically COX-3. More recently, 
evidence supports that acetaminophen may have its analgesic effects by the cannabinoid CB1 
receptor (Bertolini, 2006).  
Although IVA/P has been widely used as paracetamol outside of the United States (US), 
recently the intravenous form was approved for use in the United States as of November, 2010, 
and first available in 2011. (Shastri, 2015; FDA, 2016). IVA/P has been widely investigated for 
its use in multimodal analgesic therapies in adults. In fact, the oral form is commonly paired with 
oral opioid analgesics because of its additive analgesic effects, but no literature reviews have 
synthesized the multimodal use of IVA/P in children.   
 The aim of this systematic review and synthesis is to identify quantitative and qualitative 
studies for the use of IVA/P as a multimodal analgesic therapy, synthesize the key concepts, 
critique the research methods, identify current research gaps, and suggest future directions.  
Methods 
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The first author first met with a research librarian to develop appropriate search strategies 
for our aims. A literature search was conducted across three major bibliographic databases 
(PubMed, Embase, and Cochrane Central Register of Controlled Trials [CENTRAL]) using the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
(Moher, et al., 2009). The objective of the systematic review was first discussed between the first 
author and a research mentor (Second Author).  The aim was to gather the most comprehensive 
group of published studies exploring the use of the IVA/P and what has been published related to 
its use to manage pain with a multimodal approach during or following surgery so that this 
information could be synthesized. The goals of this literature review and the appropriate search 
strategies were then discussed with a health sciences research librarian. PubMed, Cochrane 
Central Register of Controlled Trials, and Embase were the three major bibliographic databases 
selected for this study. The search string was initially generated for use within the PubMed 
database and then adapted to be processed synonymously in the Embase database. The search 
string was adapted again for processing in Cochrane Central Register of Controlled Trials. Key 
words of the search string included, “pain*,” “Acetaminophen,” “Paracetamol,” “Ofirmev,” 
“Intravenous,” “IV,” “inject*,” “Infus*,” “catheter*,” “surg*,” “post-surgical,” “perioperative,” 
and “postoperative.” The asterisk indicates a strategy commonly used and referred to as the 
truncation character and it is used to broaden searches by replacing one or more characters 
(ProQuest, 2016). Paracetamol is another name for acetaminophen commonly used throughout 
the world. Ofirmev is the trade name associated with the IVA/P in the United States.  These 
strategies yielded a large number of articles within each of the three search engines and then 
measures were taken to further decipher whether or not the articles met our inclusion criteria.  
(Insert Figure 1 here) 
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RefWorks was used as the database for storing and tracking articles. Working with 
RefWorks can be challenging as large files are difficult to move between the bibliographic 
databases and the reference tools that were used to manage the data produced (i.e., abstracts and 
articles). To import large files, a strategy was developed with a researcher with extensive 
experience in this area of research to increase our efficiency (Havill, et al., 2014). Within 
Embase, PubMed, and CENTRAL, references can be directly exported to RefWorks. Exporting 
the citations needed to be done with 100-200 article references per file, depending on the 
database, for the RefWorks system to maintain efficiency. The consequences of reducing 
efficiency were increased lag time and incomplete import of references into RefWorks requiring 
a repeat import attempt. In Embase, the search was limited by single publication year from 1972 
to 2016. A file downloaded from Embase contained up to 100 articles within a single year, and 
was repeated until each article from that publication year made it into a corresponding file in 
RefWorks titled “Embase [year].” A synonymous process was used for both PubMed and 
Cochrane Central Register of Controlled Trials. However, in PubMed the file was able to be 
exported containing 200 references. The files exported from Cochrane Central Register of 
Controlled Trials also contained 200 references, but could only be exported by page prompting 
the first author to export by selecting several pages. Duplicates were excluded using RefWorks 
via a manual review of citations by the first author. These records were then analyzed with a new 
set of limitations for the next round of exclusions. There were three rounds of exclusions: 1) 
duplicates; 2) abstracts; and, 3) full-text articles. Abstracts and articles were evaluated for: (1) 
research that focused on IVA/P in a multimodal analgesic approach during or immediately 
following surgery; (2) focused on analgesia within the pediatric population (<18); and, (3) full-
text articles in an English language within a peer-reviewed journal. Articles were excluded if 
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they were not an original research piece, and if the article could not be obtained through 
interlibrary loan (n = 2).  
Records were assessed for eligibility by two reviewers, and a final set of five full-text 
articles were included in the final review. A data extraction form was designed by the first author 
from methods described by Harris Cooper in Research Synthesis and Meta-Analysis (p. 89-100, 
2010) with additional suggestions from the second author. The extraction form contained three 
sections: 1) general analysis; 2) study description; and, 3) data collection.. The general analysis 
section was concerned with the origin of the article, possible contributing citations accessed by 
the ancestry approach, and the nature of the publication journal. The study description section 
was concerned with the purpose of the research and important factors contributing to the quality 
of the study such as the demographics of the population, the study design, evaluating whether or 
not a power analysis was conducted, and the inclusion/exclusion criteria of the study. The data 
collection section was concerned with additional contextual factors contributing to the quality of 
the study and findings such as where the population under study was recruited from, where data 
was collected, outcomes measured, the general technique used to assess the measure, and the 
overall results of the study. The ancestry approach, as explained by Cooper (2010), was utilized 
to potentially identify additional records not found by our comprehensive database search. 
However, the records identified using the ancestry approach were all duplicate articles already 
previously identified. 
Results 
3,781 records were screened, 33 articles were not excluded by abstract review and 
eligible for full-text review, and after reviewing the articles for inclusion/exclusion criteria 5 full-
text articles (2 qualitative and 3 quantitative) were identified as meeting our inclusion criteria. 
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Figure 1 illustrates the overall review process leading to the final full-text article set. Two themes 
were derived from the full-text articles identified for review: (1) IVA/P displayed opioid-sparing 
effects and (2) use of IVA/P has positive implications for care.  
Opioid-sparring Effects 
Opioid-sparing effects were defined as those effects that seemed to be mediated by the 
addition of IVA/P and was correlated with the decreased overall consumption of opioids over 
time by the patient during pain intervention. From the studies identified, three studies 
demonstrated that IVA/P decreased the consumption for opioid analgesia over time. However, 
one study did not report a decreased consumption of opioid analgesia over time.  
(Table 1 inserted here) 
One of the four studies was a prospective observational study. Three studies randomized 
158 patients and reported on 150 patients (Ceelie, et al., 2013; Hiller, et al., 2012; Nour, et al., 
2014). 66 participants in these studies were randomized to receive an IVA/P intervention along 
with intravenous opioid (Ceelie, et al., 2013; Hiller, et al., 2012; Nour, et al., 2014). Ceelie, et al., 
reported, that the cumulative intravenous morphine dose over time in the group receiving an 
initial bolus of morphine and intermittent IVA/P was 66% lower than the group receiving an 
initial bolus of morphine followed by continuous intravenous morphine (CI 95%, 34% to 109%; 
P< .001). Pain scores in this study were measured by the Numeric Rating Scale-11 (NRS-11) and 
the COMFORT Behavior Scale (COMFORT-B), which was used to measure patient distress. In 
both groups, rescue morphine was available to patients when his or her NRS-11 indicated pain 
(score ≥ 4) and his/her COMFORT-B score indicated they were stressed (score ≥ 17). Nour, et 
al., reported that when IVA/P was administered intra-operatively, patients received less 
intravenous morphine over the 24-hour period following surgery (Intravenous group: 272.9 
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morphine equivalents [CI 95%: 202.9-342.8]; Oral group: 376.5 morphine equivalents [CI 95%: 
304.1-448.9]; Control group: 432.0 morphine equivalents [CI 95%:376.1-525.8]; P= .002). These 
patients also received less morphine in the recovery room (Intravenous group: 101.2 morphine 
equivalents [CI 95%: 67.1-149.1]; Control group: 174.8 morphine equivalents [CI 95%:120.1-
267.4]; P= .09) and on the post-surgical ward (Intravenous group: 48.9 morphine equivalents [CI 
95%: 35.4-73.5]; Control group: 96.4 morphine equivalents [CI 95%: 66.5-117.1]; P= .01) when 
compared to the control group, and the patients had a lower proportion of high pain scores (≥  4 on 
the FLACC scale or  ≥  2 on the FACES scale) for all post-operative pain scores. The study 
conducted by Nour, et al., was not blinded. Therefore, this was an individual study limitation 
because assessment and reporting of pain was done by the investigators. Hiller, et al., reported 
that overall analgesia in hours post-operatively was improved in a group receiving IVA/P (9.0% 
of hours for IV group vs. 18.4% of hours for placebo group, P < 0.01) but post-operative 
consumption of intravenous oxycodone was not reduced. Pain in this study was measured by 
visual analogue scores (VAS). Subramanyam, et al., reported in a qualitative observational study 
in which administration of IVA/P in combination with opioids reduced the use of rescue 
analgesia for breakthrough pain and reduced the costs for the hospitals involved. Three of these 
studies reported an opioid-sparring effect associated with the combined use of IVA/P 
administration. The study by Hiller, et al., reported no opioid-sparring effect, but lower pain 
scores (visual analog scale VAS score < 6) for the time spent in the post-operative ward in the 
group receiving IVA/P.  
Positive Implications for Care 
Positive implications for pediatric surgical and post-surgical care were defined as any any 
reports resulting in a positive patient outcome, indicating an impact on patient care outside of 
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opioid-sparring effects. Blanco, et al. (2013), reported a positive impact on patient care through 
presentation of a case report that described a surgical case on a 15-year old female. This case was 
important because post-operative pain control is a challenge for pediatric patients receiving 
corrective surgery for scoliosis. The authors felt that IVA/P was useful in multimodal pain 
management. The primary benefits described were: IVA/P could be used for fasting patients, 
does not sedate or cause nausea, and has the potential for decreased opioid use. Ceelie, et al., 
(2013) reported non-significant administration of naloxone in three of 39 patients in a morphine 
only group while those in the IVA/P group did not receive any other medications for analgesia. 
Patient satisfaction surveys were administered in the Nour, et al., (2014) study to evaluate the 
child’s satisfaction with the use of IVA/P. In patients randomized to receive IVA/P, patient 
analgesia satisfaction scores were higher overall compared to the control group who only 
received opioids (P = 0.03). Reduced hospital costs was another positive implication on pediatric 
surgical and post-surgical care. Subramanyam, et al. (2014), identified in a prospective 
observational study that a total cost difference of $17.12 per each tonsillectomy procedure could 
lead to overall hospital cost-savings of $9 million annually in the US. This finding is promising 
given the recent shift to value-based care in the United States, where quality needs to be 
improved and costs need to be reduced (IOM, 2001). In addition to opioid-sparring effects, 
adding IVA/P within a multimodal analgesic approach could provide positive economic 
implications for the care of pediatric patients by increasing patient satisfaction, decreasing side 
effects of current analgesic treatments focused on using opioids alone, and supporting cost-
reductions within the patient’s surgical care.  
Discussion 
Summary of Evidence 
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From this study, it is possible to gather that IVA/P may have positive implications on 
pediatric surgical and post-surgical care. However, there were such a small number of studies to 
synthesize. Therefore, more research and blinded, randomized, controlled designs are needed 
before generalizable conclusions can be made. Yet, given the data presented and what we know 
in other populations about the additive effects of acetaminophen to opioids, its potential for 
decreasing the cost of care, increasing research on IVA/P involving children would be invaluable 
because the side effects of opioids can be numerous and serious, especially in particular sub-
populations of pediatric patients who commonly have surgeries and are at risk for the side effects 
of opioids. Some of the sub-populations we are arguing for include but are not limited to  
children with cerebral palsy, intellectual impairments, and impaired respiratory or 
gastrointestinal functioning, or those having neurosurgical procedures and sedation can 
complicate ongoing neurological assessments (IOM, 2001).  
It is well established in the literature that there are many untoward effects with the use of 
opioids in many children. For example, children can experience iatrogenic opioid dependence 
and infants exposed to high doses of fentanyl have higher incidence of cerebellar injury 
(Galinkin, 2014; McPherson, 2015). Pain is reported to be more complex and from multiple 
mechanisms so it can be perceived as higher in children with intellectual disabilities (i.e., 
cerebral palsy) (Jayanath, 2015. Pain management presents a particular set of problems in the 
post-surgical management of children who have various types of brain surgery because the 
opioid sedation can interfere with necessary ongoing neurological assessments (Gottschalk,, 
Berkow, Stevens, Mirski, Thompson, & White, et al., 2007). In addition it makes sense to add 
IVA/P into the complex pain management of children who are dying and need to be made 
comfortable (Ragsdale, Zhong, Morrison, Munson, Kang, & Dai, et al.2015).  IVA/P is a 
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relatively new form of acetaminophen in the United States, with the majority of the publications 
included in this synthesis published within the last 4 years. The lack of studies reinforcing the 
pattern of opioid-sparring effects in each respective surgery type presented in Table 1 invites 
more research to be done on the addition of IVA/P in multimodal analgesic approaches.  
Limitations 
In the present study, there was a paucity of evidence to make generalizable conclusions 
other than the need for more randomized controlled pediatric trials involving IVA/P as a 
multimodal therapy so that a meta-analysis can be conducted. Establishing a quantitative 
relationship between the data and the effect sizes can help to statistically validate study findings 
(Cooper, 2010, p. 148). Another limitation to this study is a single reviewer was responsible for 
the screening and eligibility of the abstracts pulled from database searches (Liberati, et al., 2009). 
In one of the studies reviewed, a set of patients were included in the analysis even with a 
violation of the study treatment protocol (Hiller, et al., 2012). Because this set of patients 
remained in the study analysis, the results may have been biased. Variations in how pain was 
measured (e.g., patient reports versus provider observation and analog scales versus visual 
scales) in the studies and the developmental capacity of pediatric patients to discern variations in 
pain may also have had an impact on the findings. Opioid administration protocols also varied 
amongst the studies included (Ceelie, et al., 2013; Hiller, et al., 2012; Nour, et al., 2014). This 
could have an impact on the evaluation of the opioid-sparring effect of IVA/P. The fact that 
patients and clinicians were not blinded to who was receiving what type of pain control also may 
have influenced findings (Nour, et al., 2014; Subramanyan, et al., 2014). 
Conclusion 
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IVA/P is a drug with potential for an opioid-sparring effect and other positive 
implications  on the analgesic care of Adults (Memis, et al., 2010; Remy, Marret, & Bonnet, 
2005). Yet, more research is needed to ascertain the impact that the intravenous form of this drug 
could have within a multimodal approach for the pediatric surgical and post-surgical population. 
This review has identified a number of methods to be standardized within future studies for the 
evaluation of IVA/P as a multimodal analgesic therapy. For a more comprehensive identification 
of a pattern in the literature: studies should have a more consistent evaluation of pain levels 
amongst pediatric populations that is developmentally appropriate; follow a standardized 
protocol for opioid administration to identify the impact acetaminophen has on opioid 
requirements; and include secondary aims to identify any adverse or beneficial patient 
physiologic effects and patient satisfaction. Thus far, no studies have reported any untoward 
effects of adding IVA/P to a multimodal approach and therefore, IVA/P should be considered in 
a multimodal approaching children. 
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Figure 1 PRISMA flow chart of screening methods and accepted articles for review and 
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Table 1 Synthesis of Research Articles. 
	
Author,	year Aims/Purpose Study	Type #	of	Patients Age	of	Patients Inclusion	Criteria	 Measures Findings
Blanco,	2013 A	case	study	to	describe	positive	
experience	with	acetaminophen	as	a	
multimodal	approach	to	pain	
management.
Case	Report 1 15 None	Identified Pain	Assessment A	positive	case	experience	was	
described	with	the	use	of	intravenous	
acetaminophen	demonstrating	
enhanced	analgesia	without	adverse	
effects	of	opioids,	and	usefulness	in	
patients	who	are	slow	to	tolerate	oral	
pain	medications.	
Ceelie,	2013 Determine	if	intravenous	paracetamol	
reduces	cumulative	morphine	dose	
need	to	provide	adequate	analgesia	by	
at	least	30%	in	neonates	undergoing	
major	abdominal	and	(noncardiac)	
thoracic	surgery.
Single-center,	radnomized	double-
blinded	study
71 0	to	1	years	old Children	<1	year	undergoing	major	
thoracic	(non-cardiac)	or	abdominal	
surgery	between	March	2008	and	July	
2010.
Pain	and	Distress;	
Surgical	Stress;	
Cumulative	Morphine	
Dose;	Morphine	rescue	
dose;	morphine	related	
adverse	effects
In	infants	undergoing	major	surgery	
receiving	either	intermitent	
acetaminophen	or	continuous	
morphine,	cumulative	morphine	dose	
in	paracetamol	group	was	66%	less	
with	95%	CI	than	in	the	morphine	
group.
Hiller,	2012 Evaluate	pain	relieving	capacity	and	
opioid-sparing	effect	of	IV	
acetaminophen	in	adolescents	
undergoing	spine	surgery.
Randomized,	placebo-controlled,	
double	blind	study
36 15.1	(SD	2)	in	
acetaminophen	
group;	14.4	(SD	1.9)	
in	placebo	group
Major	Spine	Surgery	for	idiopathic	
scoliosis	or	spondylolisthesis.
Pain	Scores;	Adverse	
Effects;	Sedation;	and	
Venous	Blood	Samples
Intravenous	acetaminophen	provided	
better	analgesia	than	placebo,	but	did	
not	reduce	oxycodone	consumption	
after	major	spine	surgery	in	children	
and	adolescents.	
Nour,	2014 Determine	whether	oral	or	
intravenous	acetaminophen	is	an	
effective	opioid-sparing	analgesic	for	
pirmary	cleft	palate	repair	in	young	
children
Prospective	randomized	controlled	
study
45 5	months	to	5	years ASA-I	and	ASA-II	Children	ages	5-
months	to	5	years	undergoing	primary	
cleft	palate	repair	or	in	combination	
with	bilateral	myringotomy	with	
tympanostomy,	alveoplasty,	vomer	
flap,	rhinoplast,	or	cleft	lip	repair	by	
surgeons	at	Loma	Linda	University	
Children's	Hospital.
Pain	Scores;	Adverse	
Events;	and	Patient	
Satisfaction
Intravenous	acetaminophen	provided	
significant	24	hour	opioid-sparing	
effects	and	the	control	group	required	
more	resuce	analgesia	than	
intravenous	or	oral	administration	
groups	overall.	
Subramanyam,	
2014
Assess	the	cost-effectiveness	of	the	
intraoperative	combination	of	IV	
acetaminophen	and	IV	opioids	vs	IV	
opioids	alone	as	an	adjuvant	to	an	
inhalational	anesthetic	technique	for	
tonsillectomies	in	children.
Prospective	Observational	Study 139 6	years	(SD	3.4)	in	
acetaminophen	and	
opioid	group;	6.4	
years	(SD	3.4)	in	
opioid	group
Patients	undergoing	tonsillectomy	
with	or	without	adenoidectomy	
involved	in	the	primary	tonsillectomy-
related	adverse	event	study.
Effectiveness;	and	Cost Patients	in	the	combination	group	of	
intravenous	acetaminophen	and	
opioids	has	less	need	for	rescue	
analgesia	than	the	group	with	opioids	
alone	with	a	cost	difference	of	$17.12	
due	to	reduced	adverse	effects	and	
reduced	time	spent	in	the	PACU.
